One in five adults are on antidepressants. Dr. Joanna Moncrieff drops this number like it's self-evidently obscene. But nobody ever names the right number. Zero? Is zero the aspiration?

Because I've met the general population and one in five seems frankly restrained.

Here's the strongest version of what Moncrieff is actually arguing, stronger than the podcast bothered to frame it: the serotonin hypothesis was never proven in the way it was sold to patients. Pharmaceutical companies translated a research question into ad copy, doctors repeated the copy as settled neuroscience, and millions of people were handed a story about their own brains that was more metaphor than mechanism. That's a real critique. It deserves a real response, not a standing ovation or a dismissal.

But there's a move happening here that I recognize because I do it on stage. You take a legitimate point — Big Pharma oversimplified neurochemistry to move product — and you say it cleanly enough that you're technically only responsible for what you literally said. Then you leave a silence shaped exactly like the conclusion you won't say out loud, and the audience fills it in with whatever they walked in believing. Some people hear 'the chemical imbalance model is overstated' and think: good, I should explore therapy, look at systemic causes, interrogate why my job is engineered to make me feel like a product with legs. Other people hear it and think: my cousin was right, I just need cold plunges and a gratitude journal and the will to stop being weak.

Those two audiences leave the same room with opposite prescriptions and the speaker is responsible for neither. I know this trick because I've built entire sets on it — you say the dangerous thing, the laugh absorbs the shrapnel, you walk offstage technically clean. But I'm telling jokes. People don't quit their Lexapro because of my tight five. When someone with a medical degree does it on a podcast with two million downloads, the gap between interpretation A and interpretation B isn't a comedy risk — it's an emergency room visit that nobody will trace back to the episode.

A single pharmaceutical capsule resting on a bathroom shelf beside a glass of water, soft morning light from a window.
The placeholder for a conversation nobody in power wants to fund.

'If you believe you have a chemical imbalance, you do worse.' That quote is load-bearing and the building inspector never came. Worse than what? Than people who frame depression as situational? Than people who blame themselves?

Than people who were never given a framework at all and just drank?

I've been on meds. I've been off meds. The version of me that believed it was brain chemistry at least had the decency not to blame herself for every bad Tuesday. She could say: this is weather, not architecture — a storm passing through, not a flaw in the foundation. The version that believed it was all narrative and meaning-making was more interesting at dinner parties but significantly worse at being alive.

Better material, worse mornings. The Moncrieff argument, at its most generous, wants to return agency to the patient — to say you are not simply broken machinery. Fine. But agency without funded support, without accessible therapy, without anyone restructuring the conditions that made you sick, is just abandonment wearing a philosophy hat. You're free now.

Good luck out there.

The horror was never that one in five people take a pill. The horror is that the pill might be the cheapest apology a depressogenic system is willing to offer — cheaper than therapy, cheaper than restructured labor, cheaper than admitting the design is the disease. Moncrieff cracks that door. Then she walks away and lets whoever's behind her decide whether it leads to a better room or a longer fall.